Cargando…
Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity
In RNA viruses, a small increase in their mutation rates can be sufficient to exceed their threshold of viability. Lethal mutagenesis is a therapeutic strategy based on the use of mutagens, driving viral populations to extinction. Extinction catastrophe can be experimentally induced by promutagenic...
Autores principales: | Hadj Hassine, Ikbel, Ben M’hadheb, Manel, Menéndez-Arias, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024455/ https://www.ncbi.nlm.nih.gov/pubmed/35458571 http://dx.doi.org/10.3390/v14040841 |
Ejemplares similares
-
Viral Protein VP1 Virus-like Particles (VLP) of CVB4 Induces Protective Immunity against Lethal Challenges with Diabetogenic E2 and Wild Type JBV Strains in Mice Model
por: Gharbi, Jawhar, et al.
Publicado: (2023) -
Cloning and Molecular Characterization of the Recombinant CVB4E2 Immunogenic Viral Protein (rVP1), as a Potential Subunit Protein for Vaccine and Immunodiagnostic Reagent Candidate
por: Hadj Hassine, Ikbel, et al.
Publicado: (2023) -
Extinction of Zika Virus and Usutu Virus by Lethal Mutagenesis Reveals Different Patterns of Sensitivity to Three Mutagenic Drugs
por: Bassi, Maria Rosaria, et al.
Publicado: (2018) -
Molecular Analysis of RNA-RNA Interactions between 5′ and 3′ Untranslated Regions during the Initiation of Translation of a Cardiovirulent and a Live-Attenuated Coxsackievirus B3 Strains
por: Souii, Amira, et al.
Publicado: (2013) -
The introduction of mutations in the wild type coxsackievirus B3 (CVB3) IRES RNA leads to different levels of in vitro reduced replicative and translation efficiencies
por: Gharbi, Jawhar, et al.
Publicado: (2022)